Topic
Lebrikizumab
Topic counter · /lebrikizumab
Lebrikizumab
1 piece on this counter
· 3 min
Ebglyss Cleared Hands and Feet for 53% in Trial, Lilly Seeks Label Update
In the 16-week ADtouch trial, Ebglyss cleared or almost cleared hand and foot eczema in 53% of patients versus 27% on placebo. Eli Lilly seeks an FDA label upd…
